PNT Annual CFF
$130.36 M
-$151.41 M-53.74%
31 December 2022
Summary:
As of January 22, 2025, PNT annual cash flow from financing activities is $130.36 million, with the most recent change of -$151.41 million (-53.74%) on December 31, 2022. During the last 3 years, it has risen by +$101.71 million (+355.05%).PNT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT Quarterly CFF
-$152.30 K
-$204.70 K-390.65%
30 September 2023
Summary:
As of January 22, 2025, PNT quarterly cash flow from financing activities is -$152.30 thousand, with the most recent change of -$204.70 thousand (-390.65%) on September 30, 2023. Over the past year, it has dropped by -$117.05 million (-100.13%).PNT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT TTM CFF
$13.50 M
-$117.05 M-89.66%
30 September 2023
Summary:
As of January 22, 2025, PNT TTM cash flow from financing activities is $13.50 million, with the most recent change of -$117.05 million (-89.66%) on September 30, 2023. Over the past year, it has dropped by -$103.40 million (-88.45%).PNT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.7% | -100.1% | -88.5% |
| 3 y3 years | +355.1% | - | - |
| 5 y5 years | +355.1% | - | - |
PNT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -53.7% | -100.1% | -95.3% |
POINT Biopharma Global Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$152.30 K(-390.6%) | $13.50 M(-89.7%) |
| June 2023 | - | $52.40 K(-64.1%) | $130.55 M(+0.0%) |
| Mar 2023 | - | $145.90 K(-98.9%) | $130.50 M(+0.1%) |
| Dec 2022 | $130.36 M | $13.46 M(-88.5%) | $130.36 M(+11.5%) |
| Sept 2022 | - | $116.90 M(>+9900.0%) | $116.90 M(-2949.7%) |
| June 2022 | - | $3500.00(+288.9%) | -$4.10 M(-101.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $900.00(>+9900.0%) | $261.32 M(-7.3%) |
| Dec 2021 | $281.77 M(+883.6%) | $0.00(-100.0%) | $281.77 M(0.0%) |
| Sept 2021 | - | -$4.11 M(-101.5%) | $281.77 M(-1.4%) |
| June 2021 | - | $265.43 M(+1197.9%) | $285.88 M(+1297.9%) |
| Mar 2021 | - | $20.45 M | $20.45 M |
| Dec 2020 | $28.65 M | - | - |
FAQ
- What is POINT Biopharma Global annual cash flow from financing activities?
- What is the all time high annual CFF for POINT Biopharma Global?
- What is POINT Biopharma Global annual CFF year-on-year change?
- What is POINT Biopharma Global quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for POINT Biopharma Global?
- What is POINT Biopharma Global quarterly CFF year-on-year change?
- What is POINT Biopharma Global TTM cash flow from financing activities?
- What is the all time high TTM CFF for POINT Biopharma Global?
- What is POINT Biopharma Global TTM CFF year-on-year change?
What is POINT Biopharma Global annual cash flow from financing activities?
The current annual CFF of PNT is $130.36 M
What is the all time high annual CFF for POINT Biopharma Global?
POINT Biopharma Global all-time high annual cash flow from financing activities is $281.77 M
What is POINT Biopharma Global annual CFF year-on-year change?
Over the past year, PNT annual cash flow from financing activities has changed by -$151.41 M (-53.74%)
What is POINT Biopharma Global quarterly cash flow from financing activities?
The current quarterly CFF of PNT is -$152.30 K
What is the all time high quarterly CFF for POINT Biopharma Global?
POINT Biopharma Global all-time high quarterly cash flow from financing activities is $265.43 M
What is POINT Biopharma Global quarterly CFF year-on-year change?
Over the past year, PNT quarterly cash flow from financing activities has changed by -$117.05 M (-100.13%)
What is POINT Biopharma Global TTM cash flow from financing activities?
The current TTM CFF of PNT is $13.50 M
What is the all time high TTM CFF for POINT Biopharma Global?
POINT Biopharma Global all-time high TTM cash flow from financing activities is $285.88 M
What is POINT Biopharma Global TTM CFF year-on-year change?
Over the past year, PNT TTM cash flow from financing activities has changed by -$103.40 M (-88.45%)